Routine testing showed a healthcare worker in my clinic to be nonreactive for HBsAb (antibody to the hepatitis B surface antigen) after receiving the triple-dose vaccine. What approach is recommended in this situation? After a high-risk exposure?
Original Publication Date: March 2000
LoadingThere are no recommendations at this time. Please check back later.